6533b859fe1ef96bd12b7cb2
RESEARCH PRODUCT
“Biweekly oxaliplatin plus capecitabine (OXXEL) versus oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus (OXAFAFU) in metastatic colorectal carcinoma (MCC): safety interim analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial”
Gfilippelli CsandomenicoAfarris BmassiddaDnataleGcondemi LmaiorinoEgreco SleoAgambardellaSergio Palmerisubject
year | journal | country | edition | language |
---|---|---|---|---|
2006-01-01 |